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a  b  s  t  r  a  c  t
Background:  Indication  of endoscopic  retrograde  cholangiopancreatography  (ERCP)  in  acute  biliary  pan-
creatitis  (ABP)  is  challenging.
Aims:  In  this  retrospective  study,  we  analyzed  real-world  data  to understand  the  ERCP  practice  in ABP in
Hungarian  centers.
Methods: Clinical  data  on  ABP  patients  (2013–2015)  were  extracted  from  our  large  multicentric  database.
Outcomes,  quality  indicators  and  the  role  of early  timing  of ERCP  (<24  h from  admission)  were  analyzed.
Results:  There  were  356  patients  with ABP.  ERCP  was  performed  in  267  (75%).  Performance  indicators  of
ERCP  proved  to be  suboptimal  with  a biliary  cannulation  rate  of  84%.  Successful  vs unsuccessful  cannula-
tion  of  naïve  papilla  resulted  in lower  rates  of local  [22.9%  vs  40.9%,  (P = 0.012)]  and  systemic  [4.9%  vs 13.6%,
(P = 0.042)]  complications.  Successful  vs  unsuccessful  clearance  resulted  in  lower  rates  of  local  complica-ancreatitis tions  [22.5%  vs  40.8%,  (P = 0.008)].  Successful  cannulation  and  drainage  correlated  with  less severe  course
uality indicators
egistries
of ABP  [3.6%  vs 15.9%,  (P =  0.00
rate of  local  complications  wa
24–48  h: 23.4%  (11/47);  >48h:
Conclusion:  Optimization  of  ER
ABP  without  definitive  stone  d
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The endoscopic management of acute biliary pancreatitis is
till a controversial topic. In this prospectively collected cohort
f patients in Hungary, we  found that successful cannulation and
learance at the first attempt are associated with better outcomes
nd suboptimal ERCP practices may  have a negative impact on the
utcomes of the disease.
. Introduction
Acute pancreatitis (AP) is one of the most common diseases of
he gastrointestinal tract requiring acute hospitalization; it is asso-
iated with significant morbidity and mortality worldwide with an
ncreasing incidence of 5–100/100,000 cases per year [1]. Despite
ts importance, research on pancreatitis is continuously decreasing,
uggesting that more attention should be paid to this disease [2].
One of the main etiological factors in the pathogenesis of AP
s the obstruction of the ampulla of Vater by gallstones or sludge
r by hypertrophy of papilla and bile reflux into the pancreatic
uct, contributing to 35–60% of all AP cases. This subtype of AP
s termed acute biliary or gallstone pancreatitis (ABP) [3]. Manage-
ent of ABP requires two treatment strategies in most cases. The
eneral, conservative medical treatment consists of appropriate
uid resuscitation (preferably lactated Ringer’s solution) [4], pain
anagement, and enteral nutrition in some cases [5]. The use of the
nterventional strategy in ABP to achieve biliary decompression is
till uncertain. In cases of concomitant acute cholangitis, the need
or urgent (<24 h) endoscopic retrograde cholangiopancreatogra-
hy (ERCP) is recommended. There is also a clear indication of ERCP
n cases of obstruction where biliary drainage must be properly
esolved in a short period of time [1,6–8]. On the other hand, with-
ut apparent signs of cholangitis or obstruction (manifest systemic
nflammation, biliary stones or dilatation on imaging, and jaundice
r abnormal liver function test), the indication of ERCP in the set-
ing of ABP is still debated because of the lack of available evidence
1,6]. The data provided by meta-analyses of randomized controlled
rials (RCTs), where the most recent ones analyzed 10 and 11 RCTs,
emonstrated a significant decrease in complications, hospital stay,
nd cost in patients with ABP managed with early ERCP (within
2 h) compared to conservative management [9,10]. An ongoing
CT is organized by the Dutch Pancreatitis Study Group on this still
ontroversial topic; the APEC trial is set to determine the role of
arly ERCP with biliary sphincterotomy in ABP without cholangi-
is [11]. Despite the studies noted above, optimal comprehensive
anagement of ABP is still lacking clear evidence.
The Hungarian Pancreatic Study Group (HPSG) was  created in
011 to improve patient care in pancreatic diseases and within
 short period; this organization has produced several pancreatic
egistries, trials and established guidelines [12–16]. One of its reg-
stries, concerning Acute Pancreatitis, has recorded data on AP cases
rom all participating centers throughout Hungary and now in more
han a dozen countries [17].
This study aims to determine the role of ERCP and sphinctero-
omy and stone clearance in ABP and to provide an overview of the
eneral use of ERCP in Hungary in this disease.
. Materials and methods
.1. Inclusion criteriaAll patients with AP were enrolled, and their data were prospec-
ively collected in the HPSG AP Registry, which has been approved
y the Scientific and Research Ethics Committee of the Medical
esearch Council (TUKEB-22254-1/2012/EKU). All patients wereDisease 51 (2019) 1281–1286
informed about the data collection and signed the informed consent
forms. An AP diagnosis was  made according to the recommenda-
tions in the IAP/APA guidelines, with at least two of the following
three criteria met: abdominal pain, pancreatic enzyme exceeding
more than three times the upper normal level, and features of pan-
creatitis on imaging.
In this cohort study, we selected patients who  fit the criteria
previously laid down by the Dutch Pancreatic Study Group, which
were used to determine biliary origin: (a) gallstones and/or sludge
diagnosed on transabdominal ultrasound or computed tomography
(CT) or (b) dilated CBD on ultrasound or CT (diameter: >8 mm for
age ≤75 years and diameter: >10 mm for age>75 years) or (c) two
of the following three laboratory abnormalities: (1) serum bilirubin
level >1.3 mg/dL [>40 mol/L]; (2) alanine aminotransferase (ALT)
level >100 U/L with an ALAT level greater than the aspartate amino-
transferase level; and (3) alkaline phosphatase level >195 U/L with
a gamma-glutamyltransferase level >45 U/L. Other causes of AP,
such as alcohol, hypertriglyceridemia, diet, drug-induced, trauma,
viral infection, post-ERCP, and idiopathic AP had to be absent (Sup-
plementary Table 1) [18].
691 patients with AP were enrolled in the AP registry between
January 2013 and August 2015 from 14 centers. The manuscript
was prepared in accordance with the STROBE statement [19].
2.2. Exclusion criteria
Patients under the age of 18 years and those with non-biliary
pancreatitis were excluded from the analysis.
2.3. Data extraction
Data on demographics (sex and age), etiology, severity, and mor-
tality of AP were extracted for all subjects with AP, and a descriptive
statistical analysis was performed. The severity of AP was classified
according to the revised Atlanta classification as mild, moderately
severe, and severe [20]. Main outcomes were the severity of pancre-
atitis, local (peripancreatic fluid, pseudocyst, necrosis of pancreas
on imaging, diabetes mellitus, and abdominal compartment syn-
drome) and systemic (transient or persistent organ failure based
on the modified Marshall scoring system for organ dysfunction)
complications, mortality, and length of hospital stay.
Detailed demographics, including body mass index, co-
morbidities, and data on outcomes for ERCP, were collected on
patients with ABP, such as indication of ERCP, successful cannula-
tion rate, management of CBD stones by sphincterotomy and duct
clearance, biliary and pancreatic stenting, anatomy of the papilla
(naïve/not naïve), and complication rates (bleeding and perfora-
tion). Timing of ERCP was calculated from admission. The outcomes
for ABP (severity of pancreatitis, local and systemic complications,
mortality, and length of hospital stay) were analyzed in relation
to the timing of ERCP. No follow-up was  carried out after hospital
discharge.
2.4. Statistical analysis
Continuous measures are summarized and presented as means
and standard deviations (SD) or as median and interquartile ranges
(IQR). Categorical data are presented as observed and as percent-
ages. To determine differences between continuous parameters,
depending on the distribution of the data, we used the inde-
pendent Student’s t-test or the Mann–Whitney U test for two
groups and one-way ANOVA with the Bonferroni post-hoc test
or Kruskal–Wallis test in comparing more than two groups. We
used the Chi-square test or Fisher’s exact test to analyze the rela-
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Table  1
General characteristics of the acute biliary pancreatitis cohort.
All [n (%)] Women  [n (%)] Men  [n (%)] P-value
Gender 356 204 (57.3%) 152 (42.7%) –
Age  61.65 ± 17.32 61.3 ± 18.1 62.1 ± 16.1 NS
Prior  cholecystectomy 35 (9.4%) 28 (13.9%) 7 (4.6%) 0.004










































Diabetes mellitus 59 (16.6%
Body  mass index (available for 160 women and 123 men) 28.31 ± 6
At  least 2 co-morbidities 155 (43.5
ions between the factors under examination. All analyses were
erformed with SPSS 24 statistical software (IBM Corporation).
. Results
.1. General characteristics of the AP cohort
Biliary etiology was found in 356 (51.5%) patients, and 335
48.5%) patients had other etiological factors (alcohol, hypertriglyc-
ridemia, diet, drug-induced, trauma, viral infection, post-ERCP,
nd idiopathic AP). Among the subjects with ABP, there were
ore women, and they were older than patients with a dif-
erent etiology [204/356 (57.3%) vs 106/335 (31.6%) (P < 0.001)]
nd mean age [61.5 ± 17.32 vs 51.47 ± 15.73 years (P < 0.001)]. The
ourse of pancreatitis with biliary etiology was  milder in con-
rast to non-ABP disease [mild ABP: 248/356 (69.7%) vs non-ABP:
83/335 (54.6%); moderately severe ABP: 86/356 (24.2%) vs non-
BP: 121/335 (36.1%); severe ABP: 22/356 (6.2%) vs non-ABP:
1/335 (9.2%) (P < 0.001)]. There was no difference in mortality
etween the two groups [ABP: 8/336 (2.4%) vs non-ABP: 13/322
4.0%) (P = 0.242)].
.2. Characteristics of the ABP cohort
A pancreatitis diagnosis was based on upper abdominal pain and
levated pancreatic enzymes in 327/356 (91.8%) of the patients.
ABP occurs more commonly in women [204/356 (57.3%) female
s 152/356 (42.7%) male]. In almost 10% of the cases, ABP devel-
ped after a cholecystectomy [35/356 (9.4%)] and more frequently
n women [28/204 (13.9%) vs 7/152 (4.6%) (P = 0.004)].
Diabetes mellitus as a co-morbidity was found in 16.6% (59/356)
f the patients, significantly more often in men  [26/204 (12.7%) vs
3/152 (21.7%) (P = 0.023)].
Age, a previously documented episode of pancreatitis, body
ass index (BMI), and co-morbidity were not different between
he two sexes. A considerable number of ABP patients had more
han two co-morbidities [43.5% (155/356)] (Table 1).
.3. Indications for ERCP
Out of the 356 patients, 267 underwent ERCP (75.0%) for sus-
ected cholangitis or cholestasis without cholangitis based on
aised inflammatory markers with dilated biliary ducts and raised
iver function tests. 89 patients in total did not undergo ERCP
lthough it would have been indicated in 50 cases of suspected
holangitis (56.2%) ERCP was not performed in these cases due to
n improving clinical picture, lack of consent from the patient, or
apid deterioration of multi-organ failure.Endoscopic ultrasonography (EUS) was performed in only five
atients, with bile duct stones being identified in two  cases. MRCP
as carried out in one patient, in which clear bile ducts were
eported.26 (12.7%) 33 (21.7%) 0.023
28.24 ± 6.03 28.40 ± 6.22 NS
85/204 (41.7%) 70/152 (46.1%) NS
3.4. Quality indicators and findings of ERCP
The key performance indicators for ERCP met  the criteria set
out in the American Society of Gastrointestinal Endoscopy (ASGE)
guidelines [21]. Successful biliary cannulation was  achieved in 233
subjects with naïve papilla (90.7%), but the successful cannulation
rate was  84.0% (216 procedures) at first attempt. In 80 subjects,
extractions of stones smaller than 1 cm were successful in 93.7%
of the cases. Stent implantation below the bifurcation was  success-
fully carried out in all cases after successful deep biliary cannulation
(33/33). Perforation occurred in 1/267 (0.4%) of the cases. Clinically
significant bleeding requiring blood transfusion developed in 3/267
(1.2%) of the patients.
Common bile duct (CBD) stones, sludge, and/or dilation of the
bile ducts were reported in 97 (36.3%), 91 (34.1%), and 124 (46.4%)
cases, respectively. Spontaneous passage of a bile duct stone was
suspected in 19.5% (52/267) of the patients during ERCP. In 30 cases
(11.2%), no biliary pathology was  found by ERCP. Endoscopic ultra-
sound was  only carried out in five cases because of limited access
at the time of data collection.
315 ERCPs were performed in 267 patients until completion
or abandoning the intervention or treatment. 43 patients had two
ERCPs, and five had three procedures.
3.5. Outcomes for ABP in relation to success rates of ERCP
Data on cannulation success rate and clearance of the bile ducts
were available in all cases. The success rate for bile duct cannulation
in all patients was  83.5% (223/267) during the first ERCP, and any
further endoscopic attempts resulted in a higher rate of success
[90.6% (242/267)]. Successful cannulation was achieved in 84.0%
(216/257) of patients with naïve papilla, and clearance of the bile
duct was successful in 71.5% (191/267) at the first ERCP attempt.
Endoscopic biliary sphincterotomy was  done in 86.5% (231/267) of
the ERCPs, whereas pancreatic sphincterotomy was  only performed
in 1.12% (3/267) of the cases. Biliary stents were placed in 12.36%
(33/267) and pancreatic stents in 16.85% (45/267) of the cases. Suc-
cessful cannulation was  associated with significantly lower rates of
local and systemic complications. Successful clearance was  linked
to lower rates of local complications. Successful cannulation and
clearance both correlated with a less severe course of ABP and
shorter hospitalization (Tables 2 and 3).
Complete failure of clearance and decompression of the bile
ducts were related to higher frequency of local complications and
a more severe course of ABP and longer hospital stay (Table 4).
3.6. Outcomes for ABP in relation to the timing of ERCP
ERCP was performed in 75% (267/356) of the cases, the majority
of them during the first 24 h after admission.
Data on the timing of ERCP were available in 256 (95.9%) cases.
ERCP was performed on 64.8% (166/256) of the patients within 24 h
after admission, in 18.4% (47/256) of them between 24 and 48 h
after admission, and in 16.8% (43/256) cases later than 48 h after
admission. A tendency of an increased rate of local complications
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Table 2
Successful cannulation versus failure to cannulate the common bile duct with the first endoscopic retrograde cholangiopancreatography in the acute biliary pancreatitis
cohort.
Successful bile duct cannulation with 1st ERCP [n (%)] Failure to cannulate the bile duct with 1st ERCP [n (%)] P-value
Total (n = 267) 223 (83.5%) 44 (16.5%) –
Rates  of severe disease 8 (3.6%) 7 (15.9%) 0.001
Local  complications 51 (22.9%) 18 (40.9%) 0.012
Systemic complications 11 (4.9%) 6 (13.6%) 0.042
Mortality 4 (1.8%) 1 (2.3%) NS
Hospital stay, median (IQR) 9 (6–13) 14 (8–21.5) 0.00021
Table 3
Successful clearance versus failure to achieve clearance of the common bile duct for all endoscopic retrograde cholangiopancreatographies in the acute biliary pancreatitis
cohort.
Successful bile duct clearance [n (%)] Failure of clearance the bile duct [n (%)] P-value
Total (n = 267) 218 (81.6%) 49 (18.3%) –
Rates  of severe disease 9 (4.1%) 6 (12.2%) 0.033
Local  complications 49 (22.5%) 20 (40.8%) 0.008
Systemic complications 13 (6.0%) 4 (8.2%) NS
Mortality 4 (1.8%) 1 (2.0%) NS
Hospital stay, median (IQR) 9 (6–13) 11 (7–21) 0.021
Table 4
Successful clearance versus failure of clearance and decompression of common bile duct for all endoscopic retrograde cholangiopancreatographies in the acute biliary
pancreatitis cohort.
Successful clearance of bile duct [n (%)] Unsuccessful clearance and decompression of bile duct [n (%)] P-value
Total 218/267 (81.6%) 32/250 (12.8%) –
Rates of severe disease 9 (4.1%) 6 (18.7%) 0.001
Local  complications 49 (22.5%) 16 (50.0%) 0.001
Systemic complications 13 (6.0%) 4 (12.5%) NS
Mortality 4 (1.8%) 1 (3.1%) NS
Hospital stay median (IQR) 9 (6–13) 16 (8.5–24.5) 0.001
Table 5
Outcomes for acute biliary pancreatitis in relation to the timing of endoscopic retrograde cholangiopancreatography in all patients with acute biliary pancreatitis.
<24 h[n (%)] 24–48 h[n (%)] >48 h[n (%)] P-value
Total (n = 256) 166 (64.8%) 47 (18.36%) 43 (16.80%) –
Rates  of severe disease 5 (3%) 3 (6.4%) 3 (7.0%) NS
Local  complications 35 (21.1%) 11(23.4%) 16 (37.2%) 0.088
Systemic complications 7 (4.2%) 4 (8.5%) 4 (9.3%) N/A*

















Hospital stay, median (IQR) 8 (6–12) 
* Statistical analysis was not carried out in cases of systemic complications, mort
as observed if ERCP was  performed later [ERCP in 24 h: 21.1%
35/166); between 24 and 48 h: 23.4% (11/47); after 48 h: 37.2%
16/43) (P = 0.088)].
We note that only 1.1% (7/267) of the endoscopic interventions
escribed signs of purulent cholangitis.
The length of hospitalization was significantly longer in all
atients if ERCP was delayed (Table 5).
.7. Other relevant findings
There was no statistically significant difference in the outcomes
or ABP between the patients treated with or without ERCP. (Sup-
lementary Table 2).
Use of antibiotics was a common practice. 87.6% (312/356) of
ll the patients received antibiotics, for which the indication was
uspected cholangitis in 85.3% (266/312). They were administered
o treat infections outside the biliary tree, such as pneumonia and
rinary tract infections, in 11.9% (37/312) of the cases. The first
hoice among antibiotics for cholangitis was a combination of a
ephalosporin and metronidazole.0 (5.5–15) 13 (9.5–21) <0.001
and rates of severe disease due to low numbers of subjects.
4. Discussion
Prospectively collected, real-world data were analyzed in this
multicenter study, and considerable coverage of Hungarian acute
biliary pancreatitis cases is presented. Data shown above depict
current management strategies used in Hungary.
Although a clear-cut diagnosis of definite cholangitis would
have been desirable in our analysis, currently there is no vali-
dated definition of cholangitis in the setting of ABP. Simple AP
can result in a transient and self-resolving biliary obstruction with
deranged liver function tests and dilated biliary tree, which can
mimic  cholangitis with the raised inflammatory markers driven by
pancreatitis. Thus the use of the definition of definite cholangitis as
termed by the Tokyo criteria had to be avoided [18].
As described in other studies, we  found that patients with ABP
are older, and there are more women among them compared to AP
of other etiologies [3]. In the Hungarian cohort, ABP tended to have
a less severe natural course, but the mortality was the same as in
other etiologies, as reported in a large study [2].Previous cholecystectomy was relatively common and more so
in women. This could be explained by the fact that biliary stone
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allbladder increases the risk of ABP, most likely even after a pre-
ious cholecystectomy. A previously documented episode of AP
ccurred in more than 10% of the patients. Although data on the
tiology of the previous attack was not available, we  believe that
he majority of the cases were likely driven by gallstone disease,
imilar to data reported by Godi et al. [12]. Diabetes is a known
isk factor for AP, and significantly more men  had diabetes in the
ungarian cohort, which was reported in AP with all etiologies [15].
ERCP was performed in 75% of the patients presenting with ABP.
o our best knowledge, there are no previous cohort studies where
he rate of ERCP was published and analyzed. We  found that our
RCP practice in ABP is in line with the current guidelines; however,
e must highlight that very limited access to urgent endoscopic
ltrasound (EUS) and magnetic resonance cholangiopancreatogra-
hy (MRCP) resulted in a number of avoidable ERCPs. At the same
ime, a small proportion of the patients with suspected cholangitis
ere not amenable to ERCP. In summary, we believe that ERCP for
BP will be reduced as access to EUS and MRCP improves. In most
ases, the indication was suspected cholangitis, and these are the
atients who could have benefited most from additional diagnostic
maging [16,19,22].
Our results clearly demonstrated that the lack of access to addi-
ional diagnostic tools (EUS or MRCP) resulted in a high number of
nnecessary and avoidable ERCPs, and this clinical practice needs
o be improved.
Some of the key performance indicators describing the ERCP
ractices in this large cohort across many centers described sub-
ptimal ERCP practices. Most importantly a success rate of 84% at
rst attempt (216 patients), which is below the quality benchmark
f >90% recommended by ASGE. This may  well be driven by the
act that some of the ERCPs were performed in low volume centers.
t also reminds us that, if indicated, high-quality ERCP with maxi-
al  pancreas protection and high competence of alternative biliary
ccess techniques should be mandatory.
One of our main findings is that failed cannulation and bile duct
learance are associated with a higher incidence of local compli-
ations and severity of ABP. This result can be interpreted in two
ays. Firstly, successful clearance and decompression of the bile
ucts can result in a quicker resolution of pancreatitis and less pro-
ression leading to complications. Secondly, it may  be explained
y the difficult access to the bile ducts in already complicated AP,
riven by difficult intubation of the duodenum, poor visualization
f the papilla, limited maneuverability of the duodenoscope, and
hallenging cannulation of the edematous papilla. ERCPs are there-
ore done for the indication of acute biliary pancreatitis classified
s grade 3 difficulty on the modified Schutz grade, on a scale of 1–4,
here 4 is the most difficult [23].
In this situation, high success rates can only be expected of com-
etent, highly skilled endoscopists with substantial case numbers.
his is how we explain the slightly suboptimal quality indicators
ASGE guideline) of ERCP in this cohort [19]. Cannulation of naïve
apilla was successful at first attempt in 84.1% of all ERCPs (desired:
0%), perforation occurred in 0.4% (desired: ≤0.2%), and bleeding
equiring transfusion resulted in 1.2% (desired: ≤1%). We note that
his analysis contained data from 267 patients, hence the two lat-
er measures. Quality indicators of stone extraction and stenting of
bstructions below the level of bifurcation met the criteria for the
uidelines.
We did not find a significant decrease in the rate of local compli-
ations and hospital stay in the cohort when ERCP was performed
ithin two days. Evidence suggests that early ERCP in ABP with
holangitis is indicated [1,6–8], but our findings could not rein-
orce these previous data. In patients with a clear-cut diagnosis of
cute cholangitis, ERCP should be considered as soon as possible to
rovide a better outcome [24].Disease 51 (2019) 1281–1286 1285
Just like the need for ERCP, the high rate of antibiotic use
reported in our study (87.6%) could possibly be reduced by bet-
ter access to EUS and MRCP in the case of suspected cholangitis.
However, cholangitis is one of the most feared sources of abdom-
inal infection and can lead to sepsis, multiple organ failure, and
death. Therefore, any strategy to delay or withhold antibiotics in the
context of suspected cholangitis should be carefully assessed. Edu-
cational activities should be organized and materials disseminated
to ensure strict adherence to international guidelines [1,6].
4.1. Strengths and weaknesses of the study
This cohort represents a general, diverse, multicenter (not only
tertiary centers participated), acute biliary pancreatitis sample.
For this reason, broader, more generalizable conclusions could be
drawn. Limitations of this study are the relatively low case numbers
in subgroups and the retrospective design with post-hoc question
raising, which is susceptible to biases, thus limiting the conclusions
considerably. Lastly, a large number of participating ERCP units
without a structured approach to the timing of ERCP procedures
in ABP limits the statistical conclusions on associations with the
outcomes of pancreatitis.
5. Conclusion
The indication and benefit of ERCP in patients with ABP but
without a clear-cut diagnosis, cholangitis remains a contentious
issue. We  recommend that the non-invasive diagnostic approach
should be maximized to select the most suitable subgroup of these
patients. As ERCP is difficult in ABP, quality indicators must be
closely monitored, and procedures should be performed by experts
in high-volume centers as suboptimal ERCP practices are likely to be
associated with poorer outcomes of the acute biliary pancreatitis.
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